Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.


TSX:MSCL - Post by User

Post by DrHolidayon Jun 20, 2018 4:31pm
155 Views
Post# 28201609

Stock still cheap!

Stock still cheap!Yes, you run with your winners, and smart buyers today took their chips and bought the dip on any weakness to go long and strong. Time to average up even if you bought this baby lower.

Yeah, sweet little sixteen! .16 cents.
Sorry, missed it by half a cent.............165 oops!
This close at the HOD (high of day) on very strong volume bodes well for tomorrows trading, and I can`t predict what will happen tomorrow until I consult with the swami. 20 cents is a guess.
He knows all, and sees all. Yes!

Shareholders who have been waiting patiently with great stamina are finally seeing some big upside and the fruits of wise investing. Know your company management and know where we are in the product pipeline cycle.

DOC.
<< Previous
Bullboard Posts
Next >>